Exicure, Inc. Announces Significant Board and Executive Changes

Exicure, Inc. (NASDAQ: XCUR) has filed a Form 8-K with the Securities and Exchange Commission dated April 10, 2026, detailing significant changes to its board and executive management. These developments may be material to shareholders and could impact the company’s share price.

Key Points and Details

• Board Appointment:
  • On April 8, 2026, Exicure’s Board of Directors appointed Yoontae Han as a director, effective immediately. Mr. Han will serve until a successor is elected or until his earlier death, resignation, or removal.
  • Mr. Han was also appointed to the Audit Committee of the Board. This committee is critical for overseeing financial reporting and compliance.
  • Dongho Lee, a current member of the Audit Committee, has been appointed as Chair of the Audit Committee.
  • Mr. Han will receive an annual retainer of \$20,000 for his board services. He will enter into an indemnification agreement, standard for Exicure directors.
  • There are no material relationships or transactions involving Mr. Han that require disclosure under SEC regulations. There are also no arrangements with other persons regarding his appointment.
• Executive Management Change:
  • On April 9, 2026, Young Seung Ko was appointed as the Chief Operating Officer (COO) of Exicure. Mr. Ko brings over 20 years of global experience in enterprise software, data infrastructure, and public company operations.
  • From September 2022 to March 2025, Mr. Ko served as CEO and Director of AGEDB Technology Ltd. (TSXV: AGET), a Canadian hybrid database technology company. He led AGEDB through its public listing on the TSX Venture Exchange, oversaw international expansion, and brings strong financial oversight and regulatory compliance experience.
  • Mr. Ko studied Electrical Engineering at the University of New South Wales.
  • In connection with his appointment, Exicure amended its executive services agreement with Innocircle Advisors Inc. to include COO services. Exicure will pay an additional monthly fee of \$10,000 to Innocircle Advisors for these services.
  • Mr. Ko has no material relationships or interests in any transaction requiring disclosure, nor any arrangements with other persons regarding his appointment. He is not related to any director or executive officer of Exicure.

Potential Price-Sensitive Information for Shareholders

• Leadership Changes: The appointment of a new director, new Audit Committee Chair, and new COO represent substantial changes in Exicure’s leadership. These changes could signal a shift in strategy, governance, or operational oversight, which are often watched closely by investors.
• Audit Committee Chair Appointment: The Audit Committee is central to financial controls and compliance. Appointing a new Chair could impact internal controls, financial reporting integrity, and investor confidence.
• COO Appointment and Related Fees: The hiring of Mr. Ko—an executive with successful public listing and international expansion experience—could reflect Exicure’s intent to strengthen operations, pursue new markets, or address operational challenges. The additional \$10,000/month fee paid to Innocircle Advisors may indicate a focus on outsourcing executive functions, which could affect cost structure and operational execution.
• No Emerging Growth Company Status: Exicure indicated it does not qualify as an emerging growth company, meaning it may not benefit from certain regulatory exemptions, which could influence compliance costs and financial reporting.

Company Overview

• Headquarters: 400 Seaport Court, Suite 102, Redwood City, CA 94063
• Business: Pharmaceutical preparations
• Incorporation: Delaware
• Trading Symbol: XCUR (NASDAQ)
• Fiscal Year End: December 31
• SEC File Number: 001-39011
• EIN: 81-5333008
• Business Phone: 847-673-1700

Implications for Investors

Shareholders should closely monitor these leadership changes, as they may impact Exicure’s strategic direction, operational effectiveness, and financial reporting. Such changes are often viewed as price-sensitive, particularly for companies in transition or those seeking new growth opportunities. The appointment of an experienced COO and new director may suggest a renewed focus on execution and governance, potentially affecting investor sentiment and valuation.

Disclaimer: This article is based on information disclosed in Exicure, Inc.’s SEC filings and is intended for informational purposes only. It does not constitute investment advice, and investors should conduct their own due diligence before making investment decisions. The information is believed accurate as of the date of publication, but no warranty is provided as to its completeness or accuracy.

View EXICURE, INC. Historical chart here